Scientists probe why a key drug fails to stop dangerous Post-Birth bleeding
NCT ID NCT05488457
Summary
This study aims to understand why the standard drug oxytocin sometimes fails to prevent heavy bleeding after a C-section. Researchers will measure how the drug moves through the body and how its levels relate to the strength of uterine contractions in 100 women having planned C-sections. The goal is to gather data that could help make future treatments for postpartum hemorrhage more effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CESAREAN SECTION COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
NOT_YET_RECRUITINGStanford, California, 94305, United States
Contact Phone: •••-•••-••••
-
University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.